Degludec Glargine U300 Hospital Study

Clinical trial NCT05036876 · COMPLETED

Trial details

NCT number: NCT05036876
Sponsor: Medanta, The Medicity, India
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2021-10-10
Primary completion: 2022-03-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.